Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2007

View Archived Issues

Recent Solvay patent discloses novel therapeutic agents for gastrointestinal disorders

New therapeutic options for cardiovascular disorders claimed in recent patent literature

Novel treatment option for sepsis reported in recent Dompe patent

Recent GTx patent reports novel therapeutic agents for osteoporosis

Shire and Noven to develop new ADHD patch

Advanced Cell Technology advances retinal pigment epithelial program

New data on PBI-1393's antiinflammatory mechanism of action

Positive phase II results from Lymphoseek for cancer and melanoma

VGX International receives exclusive license of VGX-100 for gastric cancer

Oncolys and Tacere to jointly develop TT-033 for hepatitis C

LAB International licenses Fentanyl Taifun to Janssen Pharmaceutica

Positive results in pivotal phase III trial of cethromycin for CAP

Paquinimod shows steroid-sparing effects in animal models of lupus

Endometrin approved for use in assisted reproductive technology treatment

Novel selective p38 MAP kinase inhibitor described by BMS

Strong antiinflammatory activity of novel anti-C5aR antibody in animal models of arthritis

Positive topline findings from Tovaxin MS extension study

Encouraging data for GRN-163L in ongoing CLL study

New sites added to phase II trial of low-dose interferon alpha lozenges

Preclinical efficacy of a novel SARS virus vaccine strategy

European CHMP recommends approval of Sandoz's biosimilar epoetin alfa

PegIntron and Rebetol approved in E.U. for HCV patients coinfected with HIV

Symbicort pMDI available in U.S.

Supprelin LA launched for central precocious puberty

Ancaron Injection launched in Japan for arrhythmia

Satraplatin filed in E.U.

New indication approved for Tambocor in Japan

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...